Group One Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,800
| Closed | -$1.56M | – | 8847 |
|
|
2025
Q1 | $1.56M | Buy |
11,800
+1,500
| +15% | +$187K | ﹤0.01% | 2061 |
|
|
2024
Q4 | $860K | Sell |
10,300
-3,000
| -23% | -$247K | ﹤0.01% | 2714 |
|
|
2024
Q3 | $973K | Sell |
13,300
-13,300
| -50% | -$1,000K | ﹤0.01% | 2315 |
|
|
2024
Q2 | $1.82M | Sell |
26,600
-900
| -3% | -$62.4K | 0.01% | 1526 |
|
|
2024
Q1 | $1.9M | Sell |
27,500
-10,800
| -28% | -$742K | 0.01% | 1513 |
|
|
2023
Q4 | $2.74M | Buy |
38,300
+3,700
| +11% | +$213K | 0.01% | 1601 |
|
|
2023
Q3 | $1.8M | Buy |
34,600
+17,300
| +100% | +$1.01M | 0.01% | 1726 |
|
|
2023
Q2 | $1.1M | Buy |
+17,300
| New | +$1.08M | ﹤0.01% | 2275 |
|
|
2023
Q1 | – | Sell |
-36,300
| Closed | -$1.92M | – | 8102 |
|
|
2022
Q4 | $1.92M | Sell |
36,300
-2,100
| -5% | -$105K | ﹤0.01% | 1855 |
|
|
2022
Q3 | $1.79M | Buy |
38,400
+14,800
| +63% | +$773K | ﹤0.01% | 2014 |
|
|
2022
Q2 | $1.35M | Buy |
23,600
+10,800
| +84% | +$612K | ﹤0.01% | 2445 |
|
|
2022
Q1 | $783K | Sell |
12,800
-8,600
| -40% | -$447K | ﹤0.01% | 3336 |
|
|
2021
Q4 | $1.12M | Sell |
21,400
-2,800
| -12% | -$118K | ﹤0.01% | 3242 |
|
|
2021
Q3 | $902K | Buy |
24,200
+3,100
| +15% | +$108K | ﹤0.01% | 3533 |
|
|
2021
Q2 | $861K | Sell |
21,100
-1,300
| -6% | -$48.1K | ﹤0.01% | 3586 |
|
|
2021
Q1 | $760K | Sell |
22,400
-34,600
| -61% | -$1.2M | ﹤0.01% | 3547 |
|
|
2020
Q4 | $1.81M | Sell |
57,000
-122,200
| -68% | -$3.21M | ﹤0.01% | 2138 |
|
|
2020
Q3 | $4.6M | Buy |
179,200
+48,200
| +37% | +$1.1M | 0.01% | 977 |
|
|
2020
Q2 | $3.36M | Buy |
131,000
+97,900
| +296% | +$1.98M | 0.02% | 1084 |
|
|
2020
Q1 | $509K | Sell |
33,100
-1,172,300
| -97% | -$25.5M | ﹤0.01% | 2037 |
|
|
2019
Q4 | $41.4M | Buy |
1,205,400
+604,900
| +101% | +$7.26M | 0.28% | 45 |
|
|
2019
Q3 | $4.49M | Buy |
600,500
+475,100
| +379% | +$4.56M | 0.04% | 639 |
|
|
2019
Q2 | $1.63M | Buy |
125,400
+119,900
| +2,180% | +$1.54M | 0.01% | 1237 |
|
|
2019
Q1 | $67K | Sell |
5,500
-121,900
| -96% | -$1.56M | ﹤0.01% | 3426 |
|
|
2018
Q4 | $1.45M | Buy |
127,400
+17,900
| +16% | +$289K | 0.01% | 1243 |
|
|
2018
Q3 | $2.38M | Sell |
109,500
-155,100
| -59% | -$3.24M | 0.02% | 1031 |
|
|
2018
Q2 | $4.67M | Buy |
264,600
+7,300
| +3% | +$148K | 0.04% | 574 |
|
|
2018
Q1 | $5.42M | Buy |
257,300
+87,900
| +52% | +$1.71M | 0.05% | 426 |
|
|
2017
Q4 | $2.45M | Buy |
169,400
+1,200
| +0.7% | +$18.5K | 0.02% | 1069 |
|
|
2017
Q3 | $2.65M | Buy |
168,200
+119,000
| +242% | +$1.75M | 0.02% | 876 |
|
|
2017
Q2 | $611K | Buy |
49,200
+15,100
| +44% | +$175K | 0.01% | 1826 |
|
|
2017
Q1 | $554K | Buy |
34,100
+33,800
| +11,267% | +$489K | 0.01% | 1784 |
|
|
2016
Q4 | $5K | Sell |
300
-18,900
| -98% | -$267K | ﹤0.01% | 4111 |
|
|
2016
Q3 | $293K | Sell |
19,200
-16,400
| -46% | -$663K | ﹤0.01% | 2203 |
|
|
2016
Q2 | $1.38M | Sell |
35,600
-1,200
| -3% | -$43.1K | 0.02% | 1028 |
|
|
2016
Q1 | $1.02M | Buy |
36,800
+1,900
| +5% | +$63.3K | 0.01% | 1157 |
|
|
2015
Q4 | $1.88M | Sell |
34,900
-15,500
| -31% | -$782K | 0.02% | 891 |
|
|
2015
Q3 | $2.02M | Buy |
50,400
+47,800
| +1,838% | +$1.56M | 0.03% | 776 |
|
|
2015
Q2 | $83K | Buy |
+2,600
| New | +$65.9K | ﹤0.01% | 3205 |
|
Other funds holding ITCI
KIM
HNB